Essitalopram Kullanımına Bağlı Gelişen Bilateral Açı Kapanması Glokomu

Escitalopram is an antidepressant of the selective serotonin reuptake inhibitor(SSRI) class. In this manuscript, we report the case of\uda female patient who developed bilateral acute angle-closure glaucoma induced by escitalopram. A 46-year-old female patient was\udadmitted to our ophthalmology clinic with complaints of severe pain around the both eyes, headache, nausea, and vomiting for two days.\udIn her past medical history, she was using escitalopram for depression for two years. Visual acuity was at hand movement level in both\udeyes. Anterior segment examination showed bilateral diffuse conjunctival hyperemia, corneal edema, shallow anterior chamber, and fixed\uddilated pupils. Intraocular pressure was 47 mmHg in the right and 68 mmHg in the left eye. The diagnosis was acute angle-closure\udglaucoma, and the escitalopram medication was discontinued. She was treated with topical and systemic antiglaucomatous medication.\udAfter the cornea become clear, bilateral peripheral laser iridotomy was done. In the following year, she did not begin escitalopram\udmedication again and no other acute angle-closure attack was seen. (Turk J Ophthalmol 2014; 44:396-9